The partnership will run out of GlaxoSmithKline’s artificial intelligence hub in London. The drugmaker aims to use its clinical and genomic data in combination with Nvidia’s computing systems and Cambridge-1 supercomputer to drive breakthroughs for vaccine and drug discovery.
“We’re building new algorithms and approaches in addition to bringing together the best minds at the intersection of medicine, genetics and artificial intelligence in the U.K.’s rich ecosystem,” Kim Branson, PhD, GlaxoSmithKline’s senior vice president and global head of AI and machine learning, said in a news release. “This new partnership with NVIDIA will also contribute additional computational power and state-of-the-art AI technology.”
More articles on pharmacy:
Insulin in US costs up to 10 times more than in other wealthy countries, study says
Eli Lilly submits emergency authorization request for its COVID-19 antibody drug
Former vaccine official resigns from HHS months after demotion, whistleblower complaint
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
